Amneal Pharmaceuticals AMRX Earnings Call Transcripts

NASDAQ AMRX
$20.14 +0.69 (+3.55%)
At close: Nov 6, 2026 · 4:00 PM EST
14 earnings calls on file for Amneal Pharmaceuticals, from Q4 2019 to Q3 2026. Each transcript opens in a new tab.
Latest earnings call

Amneal Pharmaceuticals Q3 2026 Earnings Call

Nov 3, 2026 5,450 words · 24 min read
  • Tony DiMeoHead of Investor Relations
  • Chirag PatelCo-Founder and Co-Chief Executive Officer
  • Chintu PatelCo-Founder and Co-Chief Executive Officer
  • Tasos KonidarisChief Financial Officer
Prepared remarks and the full analyst Q&A, speaker by speaker.
Earnings calls

Amneal Pharmaceuticals Earnings Call Transcripts

Calls14
LatestNov 3, 2026
SinceQ4 2019

Fiscal 2026

Fiscal 2025

Fiscal 2021

Fiscal 2020

Fiscal 2019

All 14 Amneal Pharmaceuticals transcripts Register to get access to Amneal Pharmaceuticals’s earnings call transcripts.